Lyell Immunopharma Inc. (LYEL)
NASDAQ: LYEL
· Real-Time Price · USD
10.79
0.03 (0.28%)
At close: Aug 15, 2025, 1:15 PM
Lyell Immunopharma Fail-to-Deliver
Total FTD Shares
5
Below Average
FTD / Avg. Volume
< 0.01%
Low Impact
1-Year Change
-99.9%
Negative Trend
FTD Chart
As of Jul 10, 2025,
Lyell Immunopharma Inc. has
5
shares failed to deliver, representing 0.00%
of the average daily volume of
143,863
shares. Over the past year, the monthly average FTD is
37,752
shares, with the current level 100% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 10, 2025 | 9.77 | 5 | n/a |
| Jun 30, 2025 | 8.84 | 5 | -99.85% |
| May 30, 2025 | 8.73 | 3.29K | -53.36% |
| Apr 25, 2025 | 9 | 7.06K | +1352.47% |
| Mar 28, 2025 | 10.82 | 486 | -70.20% |
| Feb 24, 2025 | 13.3 | 1.63K | -91.59% |
| Jan 28, 2025 | 12.19 | 19.4K | +499.66% |
| Dec 30, 2024 | 12.42 | 3.23K | -1.76% |
| Nov 29, 2024 | 18.9 | 3.29K | +4290.67% |
| Oct 31, 2024 | 19.21 | 75 | -96.48% |
| Sep 30, 2024 | 27.6 | 2.13K | -96.28% |
| Aug 28, 2024 | 29 | 57.16K | +1419.68% |
| Jul 25, 2024 | 32.6 | 3.76K | -88.63% |
| Jun 27, 2024 | 27.6 | 33.08K | +8169.50% |
| May 29, 2024 | 51.2 | 400 | -77.91% |
| Apr 25, 2024 | 44 | 1.81K | -97.33% |
| Mar 06, 2024 | 52.8 | 67.83K | +503.50% |
| Feb 27, 2024 | 57 | 11.24K | +3609.24% |
| Jan 26, 2024 | 41.6 | 303 | +52.26% |
| Dec 28, 2023 | 42.2 | 199 | +53.08% |
| Nov 30, 2023 | 34.6 | 130 | -98.73% |
| Oct 30, 2023 | 35.8 | 10.21K | +35.76% |
| Sep 29, 2023 | 29.4 | 7.52K | +7420.00% |
| Aug 10, 2023 | 46.2 | 100 | -98.61% |
| Jul 31, 2023 | 57.8 | 7.2K | -78.70% |
| Jun 30, 2023 | 63.6 | 33.78K | +92.40% |
| May 31, 2023 | 63.8 | 17.56K | -47.45% |
| Apr 28, 2023 | 40.6 | 33.41K | +25.57% |
| Mar 31, 2023 | 47.2 | 26.61K | +83053.13% |
| Feb 28, 2023 | 43 | 32 | -99.55% |
| Jan 31, 2023 | 65.4 | 7.06K | n/a |